Back to search

Article

Short-Term Renal Effects of Add-On Levetiracetam in Client-Owned Dogs with Idiopathic Epilepsy Receiving Phenobarbital: A Four-Week Prospective Study

2026-07-29

Abstract excerpt

Levetiracetam (LEV) is a commonly used adjunctive antiseizure medication (ASM) in dogs because of its favorable pharmacokinetic profile and limited hepatic metabolism. However, because LEV is predominantly eliminated through renal excretion, prospective clinical evidence regarding its effects on renal function in dogs remains limited. This prospective study evaluated short-term changes in renal biomarkers during a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4db5290f-c870-5d3b-b7ea-6cc1ad724ef4
DOI
10.20944/preprints202607.2130.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Short-Term Renal Effects of Add-On Levetiracetam in Client-Owned Dogs with Idiopathic Epilepsy Receiving Phenobarbital: A Four-Week Prospective StudyDOI 10.20944/preprints202607.2130.v1
Select a neighboring publication to make it the new centre.